TY - JOUR T1 - The Survey of the Health of Wisconsin (SHOW) Program: An infrastructure for Advancing Population Health Sciences JF - medRxiv DO - 10.1101/2021.03.15.21253478 SP - 2021.03.15.21253478 AU - Kristen M.C. Malecki AU - Maria Nikodemova AU - Amy A. Schultz AU - Tamara J. LeCaire AU - Andrew J. Bersch AU - Lisa Cadmus-Bertram AU - Corinne D. Engelman AU - Erika Hagen AU - Mari Palta AU - Ajay K. Sethi AU - Matt C. Walsh AU - F. Javier Nieto AU - Paul E. Peppard Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/07/2021.03.15.21253478.abstract N2 - Purpose The Survey of the Health of Wisconsin (SHOW) was established in 2008 by the University of Wisconsin (UW) School of Medicine and Public Health (SMPH) with the goals of 1) providing a timely and accurate picture of the health of the state residents; and 2) serving as an agile resource infrastructure for ancillary studies. Today SHOW continues to serve as a vital population health research infrastructure.Participants SHOW currently includes 5,846 adult and 980 minor participants recruited between 2008-2019 in four primary waves. WAVE I (2008-2013) includes annual statewide representative samples of 3,380 adults ages 21 to 74 years. WAVE II (2014-2016) is a triannual statewide sample of 1957 adults (age ≥18 years) and 645 children. WAVE III (2017) consists of follow-up of 725 adults from the WAVE I and baseline surveys of 222 children in selected households. WAVEs II and III include stool samples collected as part of an ancillary study in a subset of 784 individuals. WAVE IV consist of 517 adults and 113 children recruited from traditionally under-represented populations in biomedical research including African Americans and Hispanics in Milwaukee county, WI.Findings to Date The SHOW provides extensive data to examine the intersectionality of multiple social determinants and population health. SHOW includes a large biorepository and extensive health data collected in a geographically diverse urban and rural population. Over 60 studies have been published covering a broad range of topics including, urban and rural disparities in cardio-metabolic disease and cancer, objective physical activity, sleep, green-space and mental health, transcriptomics, the gut microbiome, antibiotic resistance, air pollution, concentrated animal feeding operations and heavy metal exposures.Future Plans The SHOW cohort is available for continued longitudinal follow-up and ancillary studies including genetic, multi-omic and translational environmental health, aging, microbiome and COVID-19 research.Strengths and limitationsThe Survey of the Health of Wisconsin (SHOW) is an infrastructure to advance population health sciences including biological sample collection and broader data on individual and neighborhood social and environmental determinants of health.The extensive data from diverse urban and rural populations offers a unique study sample to compare how socio-economic gradients shape health outcomes in different contexts.The objective health data supports novel interdisciplinary research initiatives and is especially suited for research in causes and consequences of environmental exposures (physical, chemical, social) across the life course on cardiometabolic health, immunity, and aging related conditions.The extensive biorepository supports novel omics research into common biological mechanisms underlying numerous complex chronic conditions including inflammation, oxidative stress, metabolomics, and epigenetic modulation.Ancillary studies, such as the Wisconsin Microbiome Study, have expanded the utility of the study to examine human susceptibility to environmental exposures and opportunities for investigations of the role of microbiome in health and disease.Long-standing partnerships and recent participation among traditionally under-represented populations in biomedical research offer numerous opportunities to support community-driven health equity work.No biological samples were collected among children.The statewide sampling frame may limit generalizability to other regions in the United States.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://show.wisc.edu/ Funding StatementThis work was supported by the Wisconsin Partnership Program PERC Award [233 PRJ 25DJ and WPP4444] the National Institutes of Health Clinical and Translational Science Award [5UL RR025011] and the National Heart Lung and Blood Institute [1 RC2 HL101468]. Ongoing ancillary study funding from the National Institutes of Health Include [R21AI142481] and [R01AG061080].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Wisconsin Health Sciences Institutional Review Board 2014-0251All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData in this article may be obtained by emailing study investigators, or making a formal data request. https://show.wisc.edu/ ER -